ASCO Updates Guidelines on Bone-Modifying Drugs in Breast Cancer
ASCO releases new recommendations amid growing therapeutic options and fresh concerns about serious skeletal-related events.
The Meaning of Breast Cancer Risk and Surveillance Behaviors Among High-Risk African-American Women
A breast cancer diagnosis is a highly distressing, life-changing experience
Pollack Discusses Ongoing Research for Patients With Refractory mCRC and Other Hard-to-Treat GI Malignancies
Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium
Nivolumab/Cabozantinib Shows Continued Benefit In Frontline Treatment of RCC
Goodman Highlights Potential Benefit of SBRT in Locally Advanced Pancreatic Cancer
